What do the values in the Line of Treatment mean?
- Neoadjuvant: The patient is undergoing chemotherapy and/or radiation prior to definitive surgery. The treatment may be given to attempt to shrink the cancer so that the surgical procedure may not need to be as extensive.
- Adjuvant: The patient is undergoing chemotherapy and/or radiation after curative surgery. The treatment is given to destroy left-over (microscopic) cells that may be present after the known tumor is removed by surgery. It is also given to prevent a possible cancer reoccurrence.
- First Line: The patient will receive treatment that is not related to any surgical treatment. The treatment, has through research studies and clinical trials, been determined to have the best probability of treating a given cancer. This may also be called standard therapy.
- Second Line: The treatment is given if a disease has not responded or has reoccurred after first line treatment. Second line treatment regimens have been determined to be effective in treating a given cancer that has not responded or has reoccurred after standard therapy.
- Third Line: The patient has received two prior treatments for their cancer diagnosis, and this is the third treatment being prescribed. The treatment is given for cancer progression or recurrence after failure of first and second line therapies.
- Third Line (+): The patient has received more than two prior treatments and this is a subsequent treatment being prescribed. The prior treatments have failed to control the cancer, and this is the subsequent treatment regimen being prescribed.
- Maintenance: Therapy that is given to help keep cancer from returning after it has disappeared or is controlled without progression following an initial treatment. Maintenance therapy may be given for a longer period of time, depending on the cancer type.
What do the values in the Goal of Treatment mean?
- Curative: Refers to treatment and therapies provided to a patient with an intent to improve symptoms and cure the patient's medical problem. The goal is to place the patient into remission of his/her cancer and to sustain remission for several years.
- Non-Curative: Refers to therapies focused on slowing the spread of the cancer, management of reducing specific symptoms and improving quality of life. The goal is less than cure. Non-curative treatment is also called palliative treatment.
What is the purpose of the Deviation Report?
The Deviation report appears when the treatment plan entered deviates from evidence-based guidelines and requires medical review. The Deviation Report will show the differences between the entered treatment plan and evidence-based guidelines and/or the insurance company’s plan language, so you can clearly identify why the medical review is required.
Note: The report is not available when a Custom Treatment plan is entered.
What is the Payer Confirmation Information section on the Enter Patient Info screen? How do I locate the value that needs to be entered?
The Payer Confirmation Information section is a required section, where the field displayed coorelates to the Payer selected. The field and it's value are unique to the selected Payer.
This a required field to ensure that the correct Payer is selected during treament plan entry. The value that needs to be entered in this field can be found on the member's identifcation card.
If the value entered does not match the Payer's value, then you wil be unable to proceed past this screen and should contact the eviti Support Center for assistance.
What does checking the "Is drug off-cycle or outside of cycle" checkbox mean?
By checking this box, you are indicating that the duration of that drug’s cycle (schedule) is different than the duration of other drugs within the treatment plan. The cycle length is defined as the start of one round of drugs to the start of another.
If a drug is selected as off-cycle/outside of cycle, eviti will indicate that by displaying the term Off-Cycle in the Cycles/Cycle Range column on the treatment plan builder page.
What does checking the "Drug will be administered until the patient’s disease progresses" checkbox mean?
By checking this box, you are indicating that the patient will remain on the drug until the disease progresses or gets worse. If a drug is selected as To Progression, the term To Progression will display in the Cycles/Cycle Range column during treatment plan creation.
Note: Even when the 'To Progression' indicator displays, you will need to update/reaffirm the patient's eligibility and billing with the patient’s insurance company by the treatment plan’s End Date to ensure continued coverage.
For more information or clarification about To Progression, please contact the patient’s insurance company.